Live Breaking News & Updates on Campbellp Sparsentan

Stay updated with breaking news from Campbellp sparsentan. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

PROTECT: Sparsentan Outperforms Irbesartan in IgA Nephropathy

The 2-year data from the PROTECT study confirms the sustained benefit of sparsentan in patients with IgA nephropathy. ....

United States , Brad Rovin , Campbellp Sparsentan , Jula Inrig , National Institute Of Diabetes , Ohio State University Brad Rovin , American Society Of Nephrology , Kidney Function Decline On Health Care , Travere Therapeutics Inc , Ohio State University , American Society Of Nephrology Kidney Week , Division For Nephrology , Clinical Research Management , American Society , Nephrology Kidney Week , Ohio State , Kidney Week , Travere Therapeutics , Relative Risk , Accessed November , Kidney Function Decline , Health Care Costs , Resource Utilization , Adults With Iga Nephropathy , Filspari For Igan , Kidney Week 2023 ,